Institut Claudius Regaud
Quick facts
Marketed products
- Pharmacokinetics blood samples
- Tamoxifen, Letrozole , Anastrozole, Exemestane
- Tamoxifen, Letrozole, Anastrozole or Exemestane · Oncology
These drugs block estrogen signaling in breast cancer cells, either by directly antagonizing the estrogen receptor (tamoxifen) or by inhibiting aromatase to reduce estrogen production (letrozole, anastrozole, exemestane).
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Institut Claudius Regaud
What are Institut Claudius Regaud's marketed drugs?
Top marketed products include Pharmacokinetics blood samples, Tamoxifen, Letrozole , Anastrozole, Exemestane, Tamoxifen, Letrozole, Anastrozole or Exemestane.